Glassman Wealth Services’s MacroGenics MGNX Stock Holding History

Glassman Wealth Services’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-20	Closed	–	–	1360
2019 Q3	$0	Buy	+20	New	+$288	﹤0.01%	1243

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Glassman Wealth Services's MGNX Position: Q4 2019 in Review

Glassman Wealth Services sold out of MacroGenics (MGNX) in Q4 2019, closing a stake of 20 shares.

Glassman Wealth Services first reported a position in MGNX in Q3 2019 and held it in 1 quarter. The position peaked at $0 in Q3 2019. 124 funds tracked by Wall St. Rank hold MGNX as of Q4 2019.

Glassman Wealth Services reported no remaining MacroGenics position as of Q4 2019 after selling out during the quarter.
Glassman Wealth Services sold 20 MacroGenics shares in Q4 2019.
Glassman Wealth Services first reported a position in MacroGenics in Q3 2019 and held it in 1 quarter.
Glassman Wealth Services's MacroGenics position peaked at $0 in Q3 2019.
124 funds tracked by Wall St. Rank held MacroGenics as of Q4 2019.

Based on Glassman Wealth Services's 13F filing for Q4 2019, filed 7 Feb 2020.